Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gustave Roussy Transfert, founded in 2000 as a subsidiary of the leading European cancer center Gustave Roussy, specializes in facilitating the development and commercialization of innovations in oncology. It manages intellectual property, negotiates licenses and research contracts, supports academic and commercial partnerships, and helps launch new companies based on research from Gustave Roussy. The office has enabled multiple startups—including recent cell therapy ventures—and holds a portfolio spanning biotechnology, artificial intelligence for health care, nuclear medicine technologies, and more. Its activities are central to accelerating translational research into patient benefit.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gustave Roussy Transfert.